or
forgot password
  • cancer clinical trials in cincinnati, OH

  • Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Metastatic Breast Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Catholic Health Initiatives
    Cincinnati, Ohio 45220
    Ovarian Cancer
    A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neurofibromatosis Type 1
    OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Prostate Cancer
    Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Leukemia
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Brain and Central Nervous System Tumors
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Leukemia, Lymphoma
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Advanced Renal Cell Carcinoma
    Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Brain Cancer, Pediatric Cancers
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neuroblastoma
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    SCRI Oncology Hematology Care, Inc. Cincinnati (WST)

    Trial Locations
    SCRI Oncology Hematology Care, Inc. Cincinnati (WST)
    SCRI Oncology Hematology Care, Inc. - Cincinnati (TFT)
    SCRI Oncology Hematology Care, Inc - Cincinnati (BAM)
    SCRI Oncology Hematlogy Care, Inc. - Cincinnati (RPR)
    SCRI Oncology Hematology Care, Inc. - Cincinnati (KWD)
    SCRI Oncology Hematology Care, Inc - Cincinnati (AND)
    Breast Cancer
    Trial of Poor Performance Status Patients (ToPPS)
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Non Small Cell Lung Cancer
    Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Atypical Glandular Cell of Undetermined Significance, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection
    Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Metastatic Breast Cancer
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Charles M. Barrett Cancer Center at University Hospital

    Trial Locations
    Charles M. Barrett Cancer Center at University Hospital
    Good Samaritan Hospital Cancer Treatment Center
    Cancer
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    Good Samaritan Hospital Cancer Treatment Center
    Cincinnati, Ohio 45220
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Lymphoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Neuroblastoma
    Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Non Small Cell Lung Cancer
    Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Metastatic Breast Cancer
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Lung Cancer
    Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Metastatic Childhood Soft Tissue Sarcoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Central Nervous System Embryonal Tumor, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Childhood Visual Pathway Glioma, Unspecified Childhood Solid Tumor, Protocol Specific
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Prostate Cancer, Sexual Dysfunction
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Oncology Hematology Care
    Cincinnati, Ohio 45242
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Non-CNS Solid Tumors
    Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Acute Undifferentiated Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Prostate Cancer
    Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Leukemia
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Bethesda North Hospital

    Trial Locations
    Bethesda North Hospital
    Good Samaritan Hospital Cancer Treatment Center
    Lung Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Good Samaritan Hospital - Cincinnati

    Trial Locations
    Good Samaritan Hospital - Cincinnati
    University of Cincinnati
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Head and Neck Cancer
    Study of Blood Samples From Newborns With Down Syndrome
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Leukemia
    Multicenter Hologic Tomosynthesis Study
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Breast Cancer
    Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma
    Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Kaposiform Hemangioendotheliomas, Tufted Angioma, Capillary Venous Lymphatic Malformation, Venous Lymphatic Malformation, Microcystic Lymphatic Malformation, Mucocutaneous Lymphangiomatosis and Thrombocytopenia, Capillary Lymphatic Arterial Venous Malformations, PTEN Overgrowth Syndrome With Vascular Anomaly, Lymphangiectasia Syndromes
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
    Charles M. Barrett Cancer Center at University Hospital
    Cincinnati, Ohio 45267-0526
    Brain and Central Nervous System Tumors, Neurotoxicity
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Retinoblastoma
    A Study of Advanced or Metastatic Non-small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Cincinnati, Ohio 45267
    Non Small Cell Lung Cancer
    Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
    University of Cincinnati
    Cincinnati, Ohio 45267-0502
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    CALIPSO: Calfactant for Acute Lung Injury in Pediatric Stem Cell Transplant and Oncology Patients
    Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio 45229-3039
    Acute Lung Injury
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Charles M. Barrett Cancer Center at University Hospital

    Trial Locations
    Charles M. Barrett Cancer Center at University Hospital
    Christ Hospital Cancer Center
    Colorectal Cancer, Precancerous Condition